{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:18:21Z","timestamp":1793643501755,"version":"4.5.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T00:00:00Z","timestamp":1741392000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011077","name":"Skanes universitetssjukhus Lund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011077","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Cardiovascular Interventions"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.jcin.2025.01.451","type":"journal-article","created":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T18:33:35Z","timestamp":1744655615000},"page":"853-862","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Cangrelor During Percutaneous Coronary\u00a0Intervention in Patients With Cardiogenic Shock or Cardiac Arrest"],"prefix":"10.1016","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8777-7397","authenticated-orcid":false,"given":"Oskar Love","family":"Emilsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moman A.","family":"Mohammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Grimfj\u00e4rd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6722-8745","authenticated-orcid":false,"given":"Jonas","family":"Persson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Santos-Pardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Erlinge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasha","family":"Koul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcin.2025.01.451_bib1","first-page":"352","article-title":"Comparative review of oral P2Y12 inhibitors","volume":"43","author":"Koski","year":"2018","journal-title":"P\u00a0T"},{"key":"10.1016\/j.jcin.2025.01.451_bib2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/0091270009344986","article-title":"Pharmacokinetics and pharmacodynamics of a bolus and infusion of cangrelor: a direct, parenteral P2Y12 receptor antagonist","volume":"50","author":"Akers","year":"2010","journal-title":"J\u00a0Clin Pharmacol"},{"issue":"suppl 2","key":"10.1016\/j.jcin.2025.01.451_bib3","first-page":"15","article-title":"Clopidogrel loading dose regimens: kinetic profile of pharmacodynamic response in healthy subjects","volume":"25","author":"Savcic","year":"1999","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jcin.2025.01.451_bib4","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/1471-2261-14-189","article-title":"A\u00a0pharmacodynamic comparison of 5 anti-platelet protocols in patients with ST-elevation myocardial infarction undergoing primary PCI","volume":"14","author":"Koul","year":"2014","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.jcin.2025.01.451_bib5","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC guidelines for the management of acute coronary syndromes","volume":"44","author":"Byrne","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcin.2025.01.451_bib6","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1056\/NEJMoa0908629","article-title":"Intravenous platelet blockade with cangrelor during PCI","volume":"361","author":"Bhatt","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcin.2025.01.451_bib7","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1056\/NEJMoa1300815","article-title":"Effect\u00a0of platelet inhibition with cangrelor during PCI on\u00a0ischemic events","volume":"368","author":"Bhatt","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcin.2025.01.451_bib8","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1056\/NEJMoa0908628","article-title":"Platelet inhibition with cangrelor in patients undergoing PCI","volume":"361","author":"Harrington","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcin.2025.01.451_bib9","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/ehjcvp\/pvz002","article-title":"Clinical use of cangrelor: nationwide experience from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)","volume":"5","author":"Grimfj\u00e4rd","year":"2019","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.jcin.2025.01.451_bib10","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1161\/CIRCULATIONAHA.118.038317","article-title":"Platelet inhibition with cangrelor and crushed ticagrelor in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention","volume":"139","author":"Franchi","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2025.01.451_bib11","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1161\/CIRCULATIONAHA.120.046928","article-title":"Cangrelor, tirofiban, and chewed or standard prasugrel regimens in patients with ST-segment-elevation myocardial infarction: primary results of the FABOLUS-FASTER trial","volume":"142","author":"Gargiulo","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2025.01.451_bib12","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1161\/CIRCULATIONAHA.124.068938","article-title":"Effect of cangrelor on infarct size in ST-segment-elevation myocardial infarction treated by primary percutaneous coronary intervention: a randomized controlled trial (the PITRI trial)","volume":"150","author":"Bulluck","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2025.01.451_bib13","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1186\/s13054-014-0495-z","article-title":"Platelet aggregation and clot formation in comatose survivors of cardiac arrest treated with induced hypothermia and dual platelet inhibition with aspirin and ticagrelor; a prospective observational study","volume":"18","author":"Kander","year":"2014","journal-title":"Crit Care"},{"key":"10.1016\/j.jcin.2025.01.451_bib14","doi-asserted-by":"crossref","first-page":"780","DOI":"10.5603\/CJ.a2019.0024","article-title":"Impact of mild therapeutic hypothermia on bioavailability of ticagrelor in patients with acute myocardial infarction after out-of-hospital cardiac arrest","volume":"27","author":"Umi\u0144ska","year":"2020","journal-title":"Cardiol J"},{"key":"10.1016\/j.jcin.2025.01.451_bib15","doi-asserted-by":"crossref","first-page":"472","DOI":"10.5603\/CJ.a2022.0029","article-title":"The impact of mild therapeutic hypothermia on platelet reactivity in comatose survivors of cardiac arrest with acute myocardial infarction treated with ticagrelor","volume":"31","author":"Umi\u0144ska","year":"2024","journal-title":"Cardiol J"},{"key":"10.1016\/j.jcin.2025.01.451_bib16","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.resuscitation.2019.02.008","article-title":"Cangrelor in cardiogenic shock and after cardiopulmonary resuscitation: a global, multicenter, matched pair analysis with oral P2Y12 inhibition from\u00a0the IABP-SHOCK II trial","volume":"137","author":"Droppa","year":"2019","journal-title":"Resuscitation"},{"key":"10.1016\/j.jcin.2025.01.451_bib17","unstructured":"National Board of Health and Welfare. Coverage of national quality registers 2020 (T\u00e4ckningsgrader f\u00f6r Nationella Kvalitetsregister 2020). 2020-12-7049."},{"key":"10.1016\/j.jcin.2025.01.451_bib18","first-page":"107","article-title":"Validation of the Killip-Kimball classification and late mortality after acute myocardial infarction","volume":"103","author":"Mello","year":"2014","journal-title":"Arq Bras Cardiol"},{"key":"10.1016\/j.jcin.2025.01.451_bib19","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/pst.433","article-title":"Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies","volume":"10","author":"Austin","year":"2011","journal-title":"Pharm Stat"},{"key":"10.1016\/j.jcin.2025.01.451_bib20","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1093\/aje\/kwh090","article-title":"A\u00a0modified Poisson regression approach to prospective studies with binary data","volume":"159","author":"Zou","year":"2004","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jcin.2025.01.451_bib21","first-page":"347","article-title":"Regression-based tests for overdispersion in the Poisson model","volume":"46","author":"Cameron","year":"1990","journal-title":"J\u00a0Econometrics"},{"key":"10.1016\/j.jcin.2025.01.451_bib22","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1080\/01621459.1988.10478722","article-title":"A\u00a0test of missing completely at random for multivariate data with missing values","volume":"83","author":"Little","year":"1988","journal-title":"J\u00a0Am Stat Assoc"}],"container-title":["JACC: Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879825007897?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879825007897?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T03:43:24Z","timestamp":1745293404000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936879825007897"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":22,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S1936879825007897"],"URL":"https:\/\/doi.org\/10.1016\/j.jcin.2025.01.451","relation":{},"ISSN":["1936-8798"],"issn-type":[{"value":"1936-8798","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cangrelor During Percutaneous Coronary\u00a0Intervention in Patients With Cardiogenic Shock or Cardiac Arrest","name":"articletitle","label":"Article Title"},{"value":"JACC: Cardiovascular Interventions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcin.2025.01.451","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}